New Delhi, Aug. 12 -- Glenmark Pharmaceuticals Ltd's US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana Inc. involving allegations of price-fixing, market allocation and other anti-competitive conduct related to generic pharmaceutical products.

Glenmark Pharmaceuticals Inc., USA, will pay $15,285,369, including interest, in two instalments, the company said in a stock exchange filing on Tuesday, 11 August. Glenmark said the entire settlement amount has already been provided for in its financial statements and therefore the settlement is not expected to have a significant impact on its financial position.

The settlement relates to three complaints filed by Humana that formed part of consolidated ant...